These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 16132204

  • 1. Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome.
    Giordano R, Picu A, Broglio F, Bonelli L, Baldi M, Berardelli R, Ghigo E, Arvat E.
    Pituitary; 2004; 7(4):243-8. PubMed ID: 16132204
    [Abstract] [Full Text] [Related]

  • 2. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor.
    Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):1-17. PubMed ID: 15638864
    [Abstract] [Full Text] [Related]

  • 3. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
    Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, Giordano R, Picu A, Balbo M, Van der Lely AJ, Ghigo E, Arvat E.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
    [Abstract] [Full Text] [Related]

  • 4. Ghrelin: endocrine, metabolic and cardiovascular actions.
    Broglio F, Prodam F, Me E, Riganti F, Lucatello B, Granata R, Benso A, Muccioli G, Ghigo E.
    J Endocrinol Invest; 2005 Jun; 28(5 Suppl):23-5. PubMed ID: 16114271
    [Abstract] [Full Text] [Related]

  • 5. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
    Leal-Cerro A, Torres E, Soto A, Dios E, Deghenghi R, Arvat E, Ghigo E, Dieguez C, Casanueva FF.
    Neuroendocrinology; 2002 Dec; 76(6):390-6. PubMed ID: 12566947
    [Abstract] [Full Text] [Related]

  • 6. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [Abstract] [Full Text] [Related]

  • 7. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
    Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ, Ghigo E.
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
    [Abstract] [Full Text] [Related]

  • 8. Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas.
    Martínez-Fuentes AJ, Moreno-Fernández J, Vázquez-Martínez R, Durán-Prado M, de la Riva A, Tena-Sempere M, Diéguez C, Jiménez-Reina L, Webb SM, Pumar A, Leal-Cerro A, Benito-López P, Malagón MM, Castaño JP.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2225-31. PubMed ID: 16551736
    [Abstract] [Full Text] [Related]

  • 9. Neuroregulation of the hypothalamus-pituitary-adrenal (HPA) axis in humans: effects of GABA-, mineralocorticoid-, and GH-Secretagogue-receptor modulation.
    Giordano R, Pellegrino M, Picu A, Bonelli L, Balbo M, Berardelli R, Lanfranco F, Ghigo E, Arvat E.
    ScientificWorldJournal; 2006 Jan 17; 6():1-11. PubMed ID: 16432622
    [Abstract] [Full Text] [Related]

  • 10. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F, Gottero C, Benso A, Prodam F, Casanueva FF, Dieguez C, van der Lely AJ, Deghenghi R, Arvat E, Ghigo E.
    Clin Endocrinol (Oxf); 2003 Jan 17; 58(1):92-8. PubMed ID: 12519418
    [Abstract] [Full Text] [Related]

  • 11. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR, Nascif SO, Lengyel AM.
    Pituitary; 2006 Jan 17; 9(2):101-7. PubMed ID: 16832586
    [Abstract] [Full Text] [Related]

  • 12. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
    Arvat E, Ramunni J, Giordano R, Maccagno B, Broglio F, Benso A, Deghenghi R, Ghigo E.
    J Endocrinol Invest; 1999 Jan 17; 22(1):23-8. PubMed ID: 10090133
    [Abstract] [Full Text] [Related]

  • 13. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease.
    Giordano R, Picu A, Pagotto U, De Iasio R, Bonelli L, Prodam F, Broglio F, Marafetti L, Pasquali R, Maccario M, Ghigo E, Arvat E.
    Eur J Endocrinol; 2005 Oct 17; 153(4):535-43. PubMed ID: 16189175
    [Abstract] [Full Text] [Related]

  • 14. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
    Correa-Silva SR, Nascif SO, Molica P, Sá LB, Vieira JG, Lengyel AM.
    Clin Endocrinol (Oxf); 2010 Jan 17; 72(1):70-5. PubMed ID: 19453623
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
    Muccioli G, Baragli A, Granata R, Papotti M, Ghigo E.
    Neuroendocrinology; 2007 Jan 17; 86(3):147-64. PubMed ID: 17622734
    [Abstract] [Full Text] [Related]

  • 16. Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions.
    Broglio F, Prodam F, Riganti F, Muccioli G, Ghigo E.
    Front Horm Res; 2006 Jan 17; 35():102-114. PubMed ID: 16809926
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin, cortistatin, ghrelin and glucose metabolism.
    Gauna C, van der Lely AJ.
    J Endocrinol Invest; 2005 Jan 17; 28(11 Suppl International):127-31. PubMed ID: 16625861
    [Abstract] [Full Text] [Related]

  • 18. Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors.
    Arnaldi G, Mancini T, Kola B, Appolloni G, Freddi S, Concettoni C, Bearzi I, Masini A, Boscaro M, Mantero F.
    J Clin Endocrinol Metab; 2003 Dec 17; 88(12):5834-40. PubMed ID: 14671177
    [Abstract] [Full Text] [Related]

  • 19. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E.
    Clin Endocrinol (Oxf); 2002 May 17; 56(5):643-8. PubMed ID: 12030916
    [Abstract] [Full Text] [Related]

  • 20. Central and peripheral activities of ghrelin, a ligand of the growth hormone secretagogue receptor.
    Bona G, Bellone S.
    Panminerva Med; 2003 Sep 17; 45(3):197-201. PubMed ID: 14618118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.